Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)

Detalles Bibliográficos
Autores principales: Belgodère, Laëtitia, Pougheon Bertrand, Dominique, Jaulent, Marie Christine, Rabeharisoa, Vololona, Janssens, Walter, Rollason, Victoria, Barbot, Janine, Vernant, Jean Paul, Oualikene Gonin, Wahiba, Maison, Patrick, Ankri, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201242/
https://www.ncbi.nlm.nih.gov/pubmed/37208125
http://dx.doi.org/10.1136/bmjgh-2023-011966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201242/
https://www.ncbi.nlm.nih.gov/pubmed/37208125
http://dx.doi.org/10.1136/bmjgh-2023-011966

Ejemplares similares